Cargando…
Impaired intracortical inhibition demonstrated in vivo in people with Dravet syndrome
OBJECTIVE: Dravet syndrome is a rare neurodevelopmental disorder characterized by seizures and other neurologic problems. SCN1A mutations account for ∼80% of cases. Animal studies have implicated mutation-related dysregulated cortical inhibitory networks in its pathophysiology. We investigated such...
Autores principales: | Stern, William M., Sander, Josemir W., Rothwell, John C., Sisodiya, Sanjay M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405762/ https://www.ncbi.nlm.nih.gov/pubmed/28356460 http://dx.doi.org/10.1212/WNL.0000000000003868 |
Ejemplares similares
-
Cardiac arrhythmias in Dravet syndrome: an observational multicenter study
por: Shmuely, Sharon, et al.
Publicado: (2020) -
Case report: Dravet syndrome, feeding difficulties and gastrostomy
por: Clayton, Lisa M., et al.
Publicado: (2022) -
Audit of use of stiripentol in adults with Dravet syndrome
por: Balestrini, S., et al.
Publicado: (2016) -
The impact of COVID‐19 in Dravet syndrome: A UK survey
por: Balestrini, Simona, et al.
Publicado: (2021) -
Short‐ and long‐interval intracortical inhibition in EPM1 is related to genotype
por: Silvennoinen, Katri, et al.
Publicado: (2022)